Joint Prague-Weizmann Winter School on Drug Discovery Program
Print Full program
Monday, December 3
Time |
Session/Lecture info |
13:30-20:00 |
Monday, December 3
|
13:30-15:00 |
Registration & coffee
|
15:00-16:00 |
Opening remarks and address by the Czech ambassador to Israel
His Excellency Mr. Martin Stropnický
|
16:00-16:45 |
Petr Vachal , MSD, US
Drug Discovery Enabled
|
16:45-17:30 |
Yosef Yarden , Weizmann, IL
Treatment of lung cancer using combinations of antibodies and kinase inhibitors
|
17:30-20:00 |
Opening reception
|
Tuesday, December 4
Time |
Session/Lecture info |
08:00-22:00 |
Tuesday, December 4
|
08:00-09:00 |
Registration & coffee
|
09:00-09:45 |
Masha Niv, HUJI, IL
The relation between bitterness, toxicity and therapeutic potential
|
09:45-10:30 |
Dan Svozil, UCT, CZ
Introduction to Computational Drug Design
|
10:30-11:00 |
Coffee Break
|
11:00-11:45 |
John Overington , Medicines Discovery Catapult, UK
Data for Drug Discovery
|
11:45-13:00 |
Lunch
|
13:00-22:00 |
Tour to Jerusalem
|
Wednesday, December 5
Time |
Session/Lecture info |
08:00-18:00 |
Wednesday, December 5
|
08:00-09:00 |
Registration & coffee
|
09:00-09:45 |
Iris Alroy, Anima Biopharm, IL
Discovery of Protein Translation Modulators as Therapeutic Drugs
|
09:45-10:30 |
Miguel Weil , TAU, IL
Image based high content analysis as a platform for drug
|
10:30-11:00 |
Coffee Break
|
11:00-11:45 |
Jan Konvalinka , IOCB, CZ
Novel chemical biology tools for protein imaging and drug discovery
|
11:45-12:30 |
Lenka Maletinska, IOCB, CZ
Obesity, diabetes and Alzheimer's disease crosstalk: new therapeutic potential of anorexigenic neuropeptides
|
12:30-14:00 |
Lunch
|
14:00-14:45 |
Avigdor Schertz, Weizmann, IL
Vascular targeted photo-dynamic therapy with Tookad; The road to approved paradigm shift in cancer management
|
14:45-15:30 |
Zdenek Hostomsky , IOCB, CZ
Inhibiting PARP - from idea to registration
|
15:30-18:00 |
Poster Session
|
Thursday, December 6
Time |
Session/Lecture info |
08:00-18:30 |
Thursday, December 6
|
08:00-09:00 |
Registration & coffee
|
09:00-09:45 |
Annika Jenmalm Jensen , Karolinska Institute, SE
Chemical Biology in Drug Discovery
|
09:45-10:30 |
Paul Brennan, Oxford, UK
Chemical Probes in Target Discovery
|
10:30-10:45 |
Haim Barr, Weizmann, IL
The EU Open screen A European Chemical Biology Toolbox
|
10:45-11:15 |
Coffee Break
|
11:15-12:00 |
Vaclav Veverka, IOCB, CZ
Biomolecular NMR in knowledge-based drug design
|
12:00-12:45 |
Frank von Delft, Oxford, UK
XChem fragment screening and streamlined follow-up
|
12:45-14:15 |
Lunch
|
14:15-15:45 |
Tour of the Weizmann Campus
|
15:45-16:30 |
Nir London, Weizmann, IL
Covalent Drug Discovery
|
16:30-17:15 |
Alessio Ciulli , U. Dundee, UK
How PROTACs work
|
17:15-17:45 |
Coffee Break
|
17:45-18:30 |
Irit Sagi, Weizmann, IL
The evolution of Matrix Protease inhibitors
|
Friday, December 7
Time |
Session/Lecture info |
08:00-14:00 |
Friday, December 7th
|
08:00-09:00 |
Registration & coffee
|
09:00-09:45 |
Stephan Bachmann, Roche, CH
Catalysis as Key Technology for the Synthesis and Scale-up of APIs and Their Intermediates
|
09:45-10:30 |
Radim Nencka , IOCB, CZ
Design of novel enzyme inhibitors – PI4KB and nSMase2
|
10:30-11:00 |
Coffee Break
|
11:00-11:45 |
Chakrapani Subramanyam, Weizmann, IL / Pfizer, US
Role of Medchem in Drug discovery Collection of Vignette?s from Personal experience
|
11:45-12:30 |
David Andrews, Astra Zeneca, UK
The discovery of AZD4547
|
12:30-13:30 |
Lunch
|
13:30-14:00 |
Closing and farewell
|
Deadline for abstract submission
October 31, 2018
Notification of acceptance
November 1st 2018
Organizing committee
Nir London, WIS
Haim Barr, WIS
Martin Fusek, IOCB, Prague
Radek Cibulka, UCT, Prague
Sponsors




Coordinator & Accessibility Issues
Talia Suissa
talias@weizmann.ac.il